Enhancement of bismuth antibacterial activity with lipophilic thiol chelators

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 8, 1997, Pages 1697-1703

  Domenico, Philip ^a   Salo, Richard J ^b   Novick, Sabrina G ^c   Schoch, Paul E ^a   Van Horn, Ken ^d   Cunha, Burke A ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^c HOFSTRA UNIVERSITY   (United States)

^d WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 PROPANEDITHIOL; 3 MERCAPTO 2 BUTANOL; ANTIINFECTIVE AGENT; BISMUTH; CHELATING AGENT; DIMERCAPROL; DITHIOTHREITOL; MERCAPTAMINE; MERCAPTOETHANOL; THIOGLYCEROL; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

AGAR GEL DIFFUSION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CHELATION; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DILUTION; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG STABILITY; ESCHERICHIA COLI; HELICOBACTER PYLORI; LIPOPHILICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; PRIORITY JOURNAL; STAPHYLOCOCCUS; TEMPERATURE;

EID: 0030741936     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.8.1697     Document Type: Article

References (19)

1. 1-ATPase. Pharmacology 50: 333-337.
2. Bierer, D. W. 1990. Bismuth subsalicylate: history, chemistry, and safety. Rev. Infect. Dis. 12:S3-S8.
3. Chaleil, D., F. Lefevre, P. Allain, and G. J. Martin. 1981. Enhanced bismuth digestive absorption in rats by some sulfhydryl compounds: nmr study of complexes formed. J. Inorg. Biochem. 15:213-221.
4. Cornick, N. A., M. Silva, and S. L. Gorbach. 1990. In vitro antibacterial activity of bismuth subsalicylate. Rev. Infect. Dis. 12:S9-S10.
5. Dixon, J. S. 1995. Helicobacter priori eradication: unravelling the facts. Scand. J. Gastroenterol. 30:S48-S62.
6. Domenico, P., R. O'Leary, and B. A. Cunha. 1992. Differential effects of bismuth and salicylate salts on the antibiotic susceptibility of Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. Dis. 11:170-175.
7. Douglass, B. E., D. H. McDaniel, and J. J. Alexander. 1994. Concepts and models of inorganic chemistry, p. 463-465. John Wiley & Sons, New York, N.Y.
8. DuPont, H. L., and C. D. Ericsson. 1993. Prevention and treatment of traveler's diarrhea. N. Engl. J. Med. 328:1821-1827.
9. Figueroa-Quintanilla, D., E. Salazar-Lindo, and R. B. Sack. 1993. A controlled trial of bismuth subsalicylate in infants with acute water diarrheal disease. N. Engl. J. Med. 328:1653-1658.
10. Graham, D. Y., G. M. Lew, D. G. Evans, D. J. Evans, and P. D. Klein. 1991. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann. Intern. Med. 115:266-269.
11. Iffland, R. 1994. Bismuth, p. 269-281. In H. G. Seiler, A. Sigel, and H. Sigel (ed.). Handbook on metals in clinical and analytical chemistry. Marcel Dekker, Inc., New York, N.Y.
12. Klapötke, T. 1988. Biological activity of organometallic bismuth compounds. Biol. Metals 1:69-76.
13. Manhart, M. D. 1990. In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts. Rev. Infect. Dis. 12:S11-S15.
14. Marshall, B. J. 1990. Campylobacter pylori: its link to gastritis and peptic ulcer disease. Rev. Infect. Dis. 12:S87-S93.
15. Molina, J. A., L. Calandre, and F. Bermejo. 1989. Myoclonic encephalopathy due to bismuth salts: treatment with dimercaprol and analysis of CSF transmitters. Acta Neurol. Scand. 79:200-203.
16. Newton, G. L., and R. C. Fahey. 1995. Determination of biothiols by bromobimane labeling and high-performance liquid chromatography. Methods Enzymol. 251:148-166.
17. Slikkerveer, A. 1992. Bismuth: biokinetics, toxicity and experimental therapy of overdose. Koninklijke Bibliotheek, The Hague, The Netherlands.
18. Slikkerveer, A., and F. A. DeWolff. 1989. Pharmacokinetics and toxicity of bismuth compounds. Med. Toxicol. Adverse Drug Exp. 4:303-323.
19. Wilson, A. P. R. 1994. The dangers of BIPP. Lancet 344:1313-1314.